philippe saiag

About philippe saiag

philippe saiag, With an exceptional h-index of 62 and a recent h-index of 39 (since 2020), a distinguished researcher at Université de Versailles Saint-Quentin-en-Yvelines, specializes in the field of Dermatologie, cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them.

European consensus‐based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV‐induced dysplasia and field cancerization on …

The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concerns

Survie après immunothérapie par anti-PD-1/PD-L1 et facteurs de réponse à l’immunothérapie dans le carcinome de Merkel avancé: étude rétrospective de 81 patients

Distinct regulation of EZH2 and its repressive H3K27me3 mark in polyomavirus-positive and-negative Merkel cell carcinoma

Comparing PD-L1 scores for predicting pembrolizumab efficacy in first-line treatment of unresectable cutaneous squamous cell carcinomas.

Données de vie réelle chez des patients atteints de mélanome réséqué de stade III-IV et traités par nivolumab (NIVO) en situation adjuvante: résultats intermédiaires de l’étude …

1160P Methods of nivolumab administration in advanced melanoma: A comparison of patients’ clinical outcomes treated with flat dose or weight-adjusted dose, FLATIMEL study

philippe saiag Information

University

Position

___

Citations(all)

19396

Citations(since 2020)

9085

Cited By

13922

hIndex(all)

62

hIndex(since 2020)

39

i10Index(all)

183

i10Index(since 2020)

106

Email

University Profile Page

Université de Versailles Saint-Quentin-en-Yvelines

Google Scholar

View Google Scholar Profile

philippe saiag Skills & Research Interests

Dermatologie

cancer

Top articles of philippe saiag

Title

Journal

Author(s)

Publication Date

Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them.

European Journal of Cancer

Claus Garbe

Ana-Maria Forsea

Teresa Amaral

Petr Arenberger

Philippe Autier

...

2024/4/24

European consensus‐based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV‐induced dysplasia and field cancerization on …

Journal of the European Academy of Dermatology and Venereology

Lidija Kandolf

Ketty Peris

Josep Malvehy

Klara Mosterd

Markus V Heppt

...

2024/3/7

The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concerns

Annales de dermatologie et de venereologie

M Amini-Adle

JP Arnault

F Aubin

N Beneton

G Bens

...

2024/2/6

Survie après immunothérapie par anti-PD-1/PD-L1 et facteurs de réponse à l’immunothérapie dans le carcinome de Merkel avancé: étude rétrospective de 81 patients

Annales de Dermatologie et de Vénéréologie-FMC

C David

C Coquelle

Y Le Corre

JM L’orphelin

C Nardin

...

2023/12/1

Distinct regulation of EZH2 and its repressive H3K27me3 mark in polyomavirus-positive and-negative Merkel cell carcinoma

Journal of Investigative Dermatology

Marie-Alice Durand

Aurélie Drouin

Alice Mouchard

Laurine Durand

Clara Esnault

...

2023/10/1

Comparing PD-L1 scores for predicting pembrolizumab efficacy in first-line treatment of unresectable cutaneous squamous cell carcinomas.

Eve Maubec

Marouane Boubaya

Lydia Deschamps

Marie Beylot-Barry

Peter Petrow

...

2023/6/1

Données de vie réelle chez des patients atteints de mélanome réséqué de stade III-IV et traités par nivolumab (NIVO) en situation adjuvante: résultats intermédiaires de l’étude …

Annales de Dermatologie et de Vénéréologie-FMC

S Dalle

P Saiag

C Lebbé

JJ Grob

B Dreno

...

2023/12/1

1160P Methods of nivolumab administration in advanced melanoma: A comparison of patients’ clinical outcomes treated with flat dose or weight-adjusted dose, FLATIMEL study

Annals of Oncology

I Campo le Brun

S Dalle

L Mortier

O Dereure

S Dalac Rat

...

2023/10/1

RWD87 Retrospective Observational Study of Patients with Metastatic Merkel Cell Carcinoma (mMCC) Using the Caraderm Database Linked to the French National Health Data System (SNDS)

Value in Health

A Blom

L Mortier

I Kachaner

L Luciani

C Cahuzac

...

2023/12/1

Serious immune‐related upper gastrointestinal toxicity of immune checkpoint inhibitors: a multicenter case series

Journal of Gastroenterology and Hepatology

Clément Bresteau

Pauline Bonnet

Caroline Robert

Charlotte Mussini

Philippe Saiag

...

2023/12

Should adjuvant nivolumab be used in surgically resected Merkel cell carcinoma patients?

The Lancet

Philippe Saiag

Astrid Blom

2023/9/2

Avélumab en traitement de 1re ligne des patients atteints d’un carcinome à cellules de Merkel métastatique: analyse des données en vie réelle en France à partir de bases de …

Annales de Dermatologie et de Vénéréologie-FMC

A Blom

L Mortier

B van Hille

C Pagès

M Samimi

...

2023/12/1

1140P Cemiplimab versus historical systemic treatments for locally advanced (la) or metastatic (m) cutaneous squamous cell carcinomas (CSCC): Results from the French study TOSCA

Annals of Oncology

E Gerard

C Lebbe

E Lanoy

G Quereux

P Bernard

...

2023/10/1

Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort

Journal of the American Academy of Dermatology

Perrine Rousset

Stéphane Dalle

Laurent Mortier

Olivier Dereure

Sophie Dalac

...

2023/4/1

Quoi de neuf en oncodermatologie?: What’s new in oncodermatology?

Annales de Dermatologie et de Vénéréologie-FMC

P Saiag

2023/12/1

1181TiP BEPCOME-MB: Treatment of BRAFV600 mutated melanoma brain metastases with encorafenib+ binimetinb+ pembrolizumab with or without stereotactic radiosurgery

Annals of Oncology

P Saiag

S Gourgou

J Régis

TMS Amaral

U Leiter-Stoppke

...

2023/10/1

Résultats après arrêt de l’immunothérapie chez des patients atteints de mélanome avancé avec métastases cérébrales ayant reçu un protocole de double immunothérapie par …

Annales de Dermatologie et de Vénéréologie-FMC

C Isautier

C Lebbé

L Mortier

S Dalle

S Dalac

...

2023/12/1

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023

European Journal of Cancer

Alexander J Stratigos

Claus Garbe

Clio Dessinioti

Célèste Lebbe

Alexander van Akkooi

...

2023/11/1

Clinical features associated with outcomes and biomarker analysis of dabrafenib plus trametinib treatment in patients with BRAF-mutant melanoma brain metastases

Clinical Cancer Research

James S Wilmott

Hussein Tawbi

Johnathan A Engh

Nduka M Amankulor

Brindha Shivalingam

...

2023/2/1

Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients’ Responders to a First Course of ICI: A Multicenter National Retrospective Study of the …

Cancers

Charlée Nardin

Aymeric Hennemann

Kadiatou Diallo

Elisa Funck-Brentano

Eve Puzenat

...

2023/7/10

See List of Professors in philippe saiag University(Université de Versailles Saint-Quentin-en-Yvelines)

Co-Authors

H-index: 72
Aegerter

Aegerter

Université de Versailles Saint-Quentin-en-Yvelines

academic-engine